The DayOne Accelerator has helped launch more than 60 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Latest update: 09/09/2025
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
CliniNote
Therapeutic area: Oncology, z-Other
Country: Poland
Funding Stage: Seed
Development stage: Commercial launch
AI-powered speech recognition platform turning clinician-patient conversations into structured, interoperable medical data.
Visit website
Oncology, z-Other
Poland
Seed
Commercial launch
DATABIOMIX
Therapeutic area: Autoimmune diseases, Chronic diseases, Gastroenterology, Pain
Country: Switzerland
Funding Stage: Pre seed
Development stage: Preclinical research & prototyping
One-stop bioinformatics platforms turning microbiome sequencing data into actionable clinical and research insights.
Visit website
Autoimmune diseases, Chronic diseases, Gastroenterology, Pain
Switzerland
Pre seed
Preclinical research & prototyping
dEEGtal
Therapeutic area: Neurology
Country: Switzerland
Funding Stage: Seed
Development stage: Preclinical research & prototyping
AI-powered EEG analysis software to support faster, more accurate epilepsy diagnosis for neurologists.
Visit website
Neurology
Switzerland
Seed
Preclinical research & prototyping
Delve Health
Therapeutic area: z-Other
Country: United States
Funding Stage: Pre seed
Development stage: Commercial launch
Digital health and decentralized trial platform improving patient engagement, retention and real-world data collection.
Visit website
z-Other
United States
Pre seed
Commercial launch
Docuply
Therapeutic area: z-Other
Country: Germany
Funding Stage: Seed
Development stage: Commercial launch
Cloud eQMS for pharma and biotech SMEs to streamline audits, TMF and training management.
Visit website
z-Other
Germany
Seed
Commercial launch
epHealth
Therapeutic area: Cardiovascular diseases, Chronic diseases, Hypertension, Infectious diseases, Metabolic Diseases, Oncology, Rare Disease, Respiratory Diseases
Country: United Kingdom
Funding Stage: Seed
Development stage: Design & development
Mobile-first, end-to-end clinical trial platform integrating patients, sites and coordinating centers.
Visit website
Cardiovascular diseases, Chronic diseases, Hypertension, Infectious diseases, Metabolic Diseases, Oncology, Rare Disease, Respiratory Diseases
United Kingdom
Seed
Design & development
Ephion health
Therapeutic area: Chronic diseases, Rare Disease, Rehabilitation
Country: Spain
Funding Stage: Seed
Development stage: Regulatory approval & launch prep
AI-powered digital biomarkers from wearable gait data to monitor chronic disease progression.
Visit website
Chronic diseases, Rare Disease, Rehabilitation
Spain
Seed
Regulatory approval & launch prep
Eviive
Therapeutic area: Dermatology, Hematology, Immunology, Oncology
Country: Switzerland
Funding Stage: Pre seed
Development stage: Design & development
Liquid biopsy diagnostics using single EV biomarkers to guide personalized cancer immunotherapy decisions.
Visit website
Dermatology, Hematology, Immunology, Oncology
Switzerland
Pre seed
Design & development
Exploris Health
Therapeutic area: Cardiovascular diseases, Oncology
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
AI-based cardiac diagnostics like Cardio Explorer to detect and manage heart disease.
Visit website
Cardiovascular diseases, Oncology
Switzerland
Serie A
Commercial launch
Harmonic Discovery
Therapeutic area: Disease-agnostic, Hematology, Oncology
Country: Finland
Funding Stage: Seed
Development stage: Preclinical research & prototyping
Machine learning–driven drug discovery platform designing multi-target kinase therapeutics with precision pharmacology.
Visit website
Disease-agnostic, Hematology, Oncology
Finland
Seed
Preclinical research & prototyping
